Induction chemotherapy followed by conversion surgery for p16-positive oropharyngeal carcinoma
Human papillomavirus-induced oropharyngeal squamous cell carcinoma (p16+ OPC) is considered a unique disease entity. Despite highly successful clinical management using (chemo-) radiotherapy, late toxicities cause terrible distress to the patients. Reducing these complications and maintaining a good...
Main Authors: | Yoshiyuki Iida, Yuki Irifune, Shinichi Okada, Fuyuki Sato, Takashi Mukaigawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Otolaryngology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468548821000448 |
Similar Items
-
HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
by: Jason K. Wasserman, et al.
Published: (2017-01-01) -
Unlocking the Potential of Saliva-Based Test to Detect HPV-16-Driven Oropharyngeal Cancer
by: Kai Dun Tang, et al.
Published: (2019-04-01) -
Pathological and Virological Studies of p16-Positive Oropharyngeal Carcinoma with a Good Response to Neoadjuvant Chemotherapy
by: Daisuke Inukai, et al.
Published: (2020-09-01) -
The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
by: Miren Taberna, et al.
Published: (2018-12-01) -
The Cost of Treating Human Papillomavirus-Related Oropharyngeal Cancer
by: Houston, Karla Smalley
Published: (2019)